KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,102 | +14.3% | 36,698 | +89.0% | 0.04% | -4.9% |
| Q2 2023 | $446,420 | +87.3% | 19,418 | +141.5% | 0.04% | -28.1% |
| Q1 2023 | $238,284 | +3871.4% | 8,042 | +2912.0% | 0.06% | +5600.0% |
| Q3 2022 | $6,000 | -40.0% | 267 | -46.4% | 0.00% | -50.0% |
| Q2 2022 | $10,000 | +233.3% | 498 | +582.2% | 0.00% | +100.0% |
| Q1 2022 | $3,000 | -25.0% | 73 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -92.0% | 69 | -91.9% | 0.00% | -94.4% |
| Q3 2021 | $50,000 | +4900.0% | 848 | +3292.0% | 0.02% | – |
| Q2 2021 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $81,429,842 | 12.61% |
| Aquilo Capital Management, LLC | 782,219 | $10,872,844 | 9.85% |
| BVF INC/IL | 4,739,004 | $65,872,156 | 1.78% |
| Redmile Group, LLC | 1,868,507 | $25,972,247 | 1.24% |
| Artal Group S.A. | 1,805,346 | $25,094 | 1.08% |
| Deer Management Co. LLC | 615,895 | $8,560,941 | 1.04% |
| Avoro Capital Advisors LLC | 3,855,000 | $53,584,500 | 0.84% |
| Rock Springs Capital Management LP | 1,504,351 | $20,910,479 | 0.56% |
| AtonRa Partners | 19,172 | $266,491 | 0.56% |
| Baker Brothers Advisors | 4,750,400 | $66,030,560 | 0.38% |